EP Patent

EP1011763B1 — Injection apparatus

Assigned to Bioject Inc · Expires 2003-12-10 · 22y expired

What this patent protects

Patent listed against Lignospan Forte.

Drugs covered by this patent

Lignospan Forte (Lidocaine Hydrochloride) · Fresenius Kabi

Patent Metadata

Patent number: EP1011763B1
Jurisdiction: EP
Classification: —
Expires: 2003-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Bioject Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.